February 14, 2024 / 02:43 PM IST
Reported Standalone quarterly numbers for Pharmasia are:Net Sales at Rs 5.08 crore in December 2023 down 35.99% from Rs. 7.94 crore in December 2022.
Story continues below Advertisement
Quarterly Net Loss at Rs. 0.56 crore in December 2023 up 4.62% from Rs. 0.59 crore in December 2022.
EBITDA stands negative at Rs. 0.44 crore in December 2023 up 16.98% from Rs. 0.53 crore in December 2022.
Pharmasia shares closed at 42.08 on February 13, 2024 (BSE) and has given 71.34% returns over the last 6 months and 58.79% over the last 12 months.
| Pharmasia | | Standalone Quarterly Results | in Rs. Cr. |
|
| Dec'23 | Sep'23 | Dec'22 | | Net Sales/Income from operations | 5.08 | 8.64 | 7.94 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 5.08 | 8.64 | 7.94 | | EXPENDITURE | | Consumption of Raw Materials | 2.95 | 7.22 | 4.93 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 1.24 | -0.05 | 1.93 | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.41 | 0.41 | 0.38 | | Depreciation | 0.08 | 0.09 | 0.06 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 1.04 | 1.34 | 1.35 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -0.64 | -0.36 | -0.70 | | Other Income | 0.13 | 0.20 | 0.11 | | P/L Before Int., Excpt. Items & Tax | -0.52 | -0.16 | -0.59 | | Interest | 0.02 | 0.01 | 0.00 | | P/L Before Exceptional Items & Tax | -0.54 | -0.17 | -0.59 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -0.54 | -0.17 | -0.59 | | Tax | 0.02 | -0.01 | 0.00 | | P/L After Tax from Ordinary Activities | -0.56 | -0.16 | -0.59 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -0.56 | -0.16 | -0.59 | | Equity Share Capital | 6.83 | 6.83 | 6.83 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.83 | -0.24 | -0.87 | | Diluted EPS | -0.83 | -0.24 | -0.87 | | EPS After Extra Ordinary | | Basic EPS | -0.83 | -0.24 | -0.87 | | Diluted EPS | -0.83 | -0.24 | -0.87 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|